‌

US Patent 8703700 Bimacrocylic HCV NS3 protease inhibitors

Patent 8703700 was granted and assigned to Sequoia Pharmaceuticals on April, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Sequoia Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

87037000

Patent Inventor Names

Rongjuan Lu0

Michael Eissenstat0

Pavel Majer0

Date of Patent

April 22, 2014

Patent Application Number

133221200

Date Filed

May 24, 2010

Patent Primary Examiner

‌

Thomas Heard

Patent abstract

Inhibitors of the hepatitis C virus (HCV) NS3 protease are provided. In particular, bimacrocyclic compounds and their pharmaceutical compositions for the treatment of HCV infections are provided. Methods of making the bimacrocyclic compounds and their pharmaceutical compositions, and methods of using the compounds for treating HCV infections are also provided.